Quick answer
Coca Cola Co (KO) reported revenue of $47.94B and net income of $13.11B for the fiscal year ended 2025-12-31, up 1.9% from $47.06B the year before, per its 10-K filed with the SEC on 2026-02-20.
Data as of 2025-12-31. Source: SEC EDGAR XBRL company facts (10-K/10-Q filings)
| Fiscal year | Revenue | Net income | Long-term debt |
|---|---|---|---|
| 2025 (FY ending 2025-12-31) | $47.94B | $13.11B | — |
| 2024 (FY ending 2024-12-31) | $47.06B | $10.63B | — |
| 2023 (FY ending 2023-12-31) | $45.75B | $10.71B | $37.51B |
| 2022 (FY ending 2022-12-31) | $43.00B | $9.54B | $36.78B |
| 2021 (FY ending 2021-12-31) | $38.66B | $9.77B | $39.45B |
| 2020 (FY ending 2020-12-31) | $33.01B | $7.75B | $40.61B |
| 2019 (FY ending 2019-12-31) | $37.27B | $8.92B | $31.77B |
| 2018 (FY ending 2018-12-31) | $34.30B | $6.43B | $30.38B |
| 2017 (FY ending 2017-12-31) | $36.21B | $1.25B | $34.48B |
| 2016 (FY ending 2016-12-31) | $41.86B | $6.53B | $33.21B |
Related
- KNSL revenue, net income and debt history (Kinsale Capital Group, Inc.)
- KNTK revenue, net income and debt history (Kinetik Holdings Inc.)
- KNX revenue, net income and debt history (Knight-Swift Transportation Holdings Inc.)
- KR revenue, net income and debt history (Kroger Co)
- KRYS revenue, net income and debt history (Krystal Biotech, Inc.)
- KVUE revenue, net income and debt history (Kenvue Inc.)
- KYMR revenue, net income and debt history (Kymera Therapeutics, Inc.)
- L revenue, net income and debt history (Loews Corp)
Last updated 2026-10-16. Data only, not financial or tax advice.